$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Neural control of behavior, feeding, and metabolism involves coordination of highly complex, integrative, and redundant neurocircuits. A driving goal of the neuroscience field is to dissect the relationship between neuronal circuit structure and function. Although classical neuroscience tools (i.e., lesioning, local pharmacological injections, and electrical stimulation) have uncovered vital knowledge regarding the role of specific brain regions that control behavior and metabolism, these tools are limited by their lack of specificity and reversibility1.
Recent advances in the neuroscience field have greatly improved the ability to interrogate and manipulate circuit function in a cell-type specific manner with high spatiotemporal resolution. Optogenetic2 and chemogenetic3 approaches, for instance, allow the rapid and reversible manipulation of activity in genetically defined cell types of freely moving animals. Optogenetics involves the use of light-sensitive ion channels, termed channelrhodopsins, to control neuronal activity. Key to this technique is the gene delivery of channelrhodopsin and a source of light to activate the opsin. A common strategy for gene delivery is through a combination of 1) genetically engineered mice expressing Cre-recombinase in discrete neurons, and 2) Cre-dependent viral vectors encoding channelrhodopsin.
While optogenetics provides an elegant, highly precise means to control neuronal activity, the method is contingent upon successful stereotactic microinjection of the viral vector and fiberoptic placement into a defined brain region. Although stereotactic procedures are commonplace within the modern neuroscience lab (and there are several excellent protocols describing this procedure)4,5,6, being able to consistently and reproducibly target discrete brain regions along the midline (i.e., the mediobasal hypothalamus, a brain area critical to the regulation of homeostatic functions7) presents additional challenges. These challenges include avoiding of the superior sagittal sinus, third ventricle, and adjacent hypothalamic nuclei. In addition, there are significant spatial limitations to the bilateral implantation of hardware that is required for inhibition studies. With these challenges in mind, this protocol herein presents a modifiable procedure for targeting discrete brain regions via an angled stereotactic approach.